Reddit Posts
Mentions
their whole purpose is to make you buy their affiliated stocks. if you are curious about NUVB, you can check out my DD on it: [https://www.reddit.com/r/wallstreetbets/comments/1m3byk6/alright\_regards\_buckle\_up\_weve\_open\_the\_door\_now/](https://www.reddit.com/r/wallstreetbets/comments/1m3byk6/alright_regards_buckle_up_weve_open_the_door_now/) i add additional information every now and then on that thread. though NUVB has experienced a run, you should do your own research to know if it's worth investing your money
i don't know who OP is or what they posted but i made the first DD in wsb about NUVB months before the run up: [https://www.reddit.com/r/wallstreetbets/comments/1m3byk6/alright\_regards\_buckle\_up\_weve\_open\_the\_door\_now/](https://www.reddit.com/r/wallstreetbets/comments/1m3byk6/alright_regards_buckle_up_weve_open_the_door_now/) i still update that thread and maintain that NUVB will go way way way higher than the current price
Saw an interesting press release from $NUVL: [https://investors.nuvalent.com/nuvalent-presents-pivotal-data-from-arros-1](https://investors.nuvalent.com/nuvalent-presents-pivotal-data-from-arros-1) Nuvalent is positioning zidesamtinib as a refined ROS1 therapy that may outperform in **SPECIFIC** scenarios: brain metastases and resistance mutations. NUVB holds the upper hand with IBTROZI, zidesamtinib if approved could shift competitive dynamics. for now they are still playing catch up to NUVB but worth putting on a watchlist
Top 2 Health Care Stocks That May Plunge This Month BENZINGA - 09/05/2025 As of Sept. 5, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here's the latest list of major overbought players in this sector. **Nuvation Bio Inc (NYSE:NUVB)** On Aug. 7, Nuvation Bio (NUVB) posted in-line loss for the second quarter. “With FDA approval of IBTROZI, we’re proud of our swift evolution into a commercial‐stage company executing across functions to deliver a differentiated therapy to 70 patients in just seven weeks,” said David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio (NUVB). The company's stock gained around 44% over the past month and has a 52-week high of $3.48. RSI Value: 81.8 NUVB Price Action: Shares of Nuvation Bio (NUVB) gained 8.6% to close at $3.42 on Thursday.
Retirement plan = NUVB + hopium
As far as volume and price, NUVB appears to be the best of the lot, with a short price at 2.97.
NUVB and Beam exploding
it wasn’t me, you were smart enough to hit that buy button. Can’t wait to see what NUVB has in store for us, while succeeding a phase 3 is not guaranteed, still looking forward for the sales report this upcoming earnings.
David today at the Citibiopharma: \- Daichi to realease updated trial evidence on Safusidenib in low grade glioma updating **Progression-Free Survival (PFS)** and (maybe Overall Response Rate (ORR)? --- not sure about that one since the audio was INSANELY BAD---) \- David mentioned being in discussions with the FDA on a pivotal head to head trial against Voarsidenib. \- David confirmed advanced FDA discussions on high grade glioma pivotal study (read phase 3) \- David: “we have more than what we need to get to profitability”. NUVB is coming for a 6B market and I am all here for it. i like this stock
I forgot to mention that now I'm in NUVB, ANAB, HRTX, HUMA, CHRS, STOK SPRY, PHAT and plan to enter BEAM
KTTA Not quite penny-stocks but I can also list: RR, NUVB, KWM
David will be talking about NUVB in a bunch of conferences this week and the next. Clearly whoever is pumping is expecting good news about the Phase 2 and the adoption of the new drug after KILLING the sales only a MONTH after FDA approval. shit i like this stock. how are we doing chat? https://preview.redd.it/dwyjf9en50nf1.png?width=2156&format=png&auto=webp&s=f4797912f3f0d3f8a61c89af25d18d460ab96b55
Sudden spike in NUVB prices in PM though volume is low. Been holding well above 2.9, pretty bullish on this. Have 100 shares riding with house money.
There's nothing interesting for me. Just still holding my bag full of : ANAB, CHRS, STOK, NUVB, HUMA (maybe I'll throw it away soon) and HRTX
missed those comments but you can trust this regard, i pretty much agree with what has been said. also i got into NUVB at such a low price that my margin of safety is pretty high
NUVB has a high potential. Not a bag holder, up quite a bit (average of $2.11).
NUVB seems to finally be breaking out a week after earnings.
Ive been telling u guys for weeks… NUVB up 6% every day
Cup and handle seems to have formed for NUVB. Keep on on your watchlist!
CGTX and NUVB. Both long term plays at the right entry. CGTX is approaching short territory. #2 percent float. 11 days to cover. Today should be interesting.
NUVB short sqeeze in sight. Shorts might try to make the price dip in the morning to scare off people, but if it stay above 2.45, then goes up, they start to sweat. 32 percent float. 12 days to cover.
NUVB, I'm trying to give you thousands of dollars of game for free!
NUVB yolo 200k share fukit
I am mostly an ETF kind of guy who plays it safe. But my moonshot account is now entirely NUVB. It feels stupid reckless, but barring a Sarepta like moment, the current patient uptake makes this worth several dollars more in SP right now, leaving aside the pipeline (which is even more valuable if it emerges). Ibtrozi is clearly about to swallow 40-60% of the market year one.
Nuvation Bio (NUVB), absolutely crushed earnings estimates yet the stock barely moved. They have an FDA approved drug and have treated 70 patients in under two months. On top of that, the stock is heavily shorted, over 30% of the float with more than 20 days to cover. They also have a huge cash reserve, which reduces the risk of dilution. The volume is so low that with a little effort, we could be looking at a hidden gem.
NUVB earnings tmrw let’s goooooo
NUVB Upcoming Catalysts: - August 7: Earnings + Commercialization Update - September 6–9: New data will be presented at the IASLC 2025 World Conference on Lung Cancer (WCLC) - October 17–21: Same data presented at European Society of Medical Oncology Congress Meeting(ESMO). The data include new results from the pivotal Phase 2 TRUST-I and TRUST-II studies on the efficacy and safety of IBTROZI(taletrectinib) for the treatment of adult patients with locally advanced or metastatic ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC).
This thread might not be aware but NUVB updated their clinical trial info on July 18, 2025 indicating they have a selected dose for their Part 2 study (for an unmet need cohort). Their Part 1 study that enabled the dosing identification is intended to eat Vorasidenib’s lunch. Actually, that’s repulsively untrue, it’s to treat brain cancer. But it will may eat their 6 billion dollar lunch. They will update H2 2025 with a pivotal study. 2 days to short squeeze potential from August 7 earnings call.
Buying more NUVB calls I love this stock market thing I think people call it a dip?
Been calling NUVB for weeks if you missed I feel bad
https://preview.redd.it/i16la36utxff1.png?width=2755&format=png&auto=webp&s=6e0e56fd61aa95823e2f6dc4a93c0bdf555435f1 Bought the NUVB stonks after research, and now it has started to go down!
Small pharma -> URGN, NUVB. Done.
NUVB and HCTI shall pay my rent today
Potential breakout play for NUVB. Forming a big cup after previous catalyst.
NUVB calls for December already printing
NUVB fellas it’s not gonna stop going up
Update: August 7th NUVB will release its earning \- First sales number \- Revenu guidance \- Adoption rate of Ibtrozi \- Maybe some update regarding the phase 3 of **safusidenib** I'll pay attention to: adoption rate, burning rate and any BS the leadership might come up with. *always do your own dd, i suggest to listen to earning calls*
NUVB is the next big play, could be another OPEN
Thanks for the additional vectors to consider. I did see a lot rug pulls with companies like NUVB only just making it's way back to the previous price spikes despite the relatively decent news. Definitely agree on covering cost basis and taking some profit at least, the run up has been amazing but doesn't feel sustainable at all. Correction feels imminent even with good news, though it may present another opportunity to at least buy the dip if the top line data holds promise over AD109.
NUVB is a strong buy and hasn’t hit a high yet
NUVB, stock took of this morning and is relatively low cost for calls. Would advise a peek
NUVB thank you for turning your life around
What do you all know about Nuvation Bio(NUVB) buy or no buy? Simple, straight to the point. Thank you!
NUVB I’ve been saying it and it’s still early enough
NUVB 200% return rate- 25% of my portfolio rn
Most effort I've seen recently. I'll sell my NUVB calls for now and buy DNUT instead. Goddamnit.
Personally I think the next meme stock is NUVB - it's volume has more than doubled on the daily and is holding pretty well - and some regard posted some decent DD so I went all in - need more regarded apes.
OPEN for the win, guys watch out for NUVB
NUVB fellas get in while it’s cheap
NUVB and OPEN will make me plenty of moneys
Anyone get in on NUVB Friday?
NUVB we will come back to this next week for further review
This is an interesting company. I also like AMPX and NUVB.
NUVB was the plan baby, eat it haters! PWDY was another good one too. LMFAO I'm on a roll, HYSR is my next gamble!
What’s going on with NUVB? Jumped up big today and I have about 240 shares.
Anyone still holding for NUVB?
I have 3 that I'm holding for long term. So far, they have been steady for me. Def NFA. I'm newer to this side of the market. Trying to learn more each day. NUVB DNN OVID (still debating)
NUVB out with some positive news https://investors.nuvationbio.com/news/news-details/2025/Nuvation-Bio-Announces-National-Comprehensive-Cancer-Network-Adds-Taletrectinib-IBTROZI-as-Preferred-Option-to-Clinical-Practice-Guidelines-in-Oncology-for-Advanced-ROS1-Non-Small-Cell-Lung-Cancers/default.aspx
I only went in with NINE & ECDA, profits on both, I’m still unsure if EONR will break, it keeps getting close but then going back down, good for profiting off the fluctuation but I could be wrong, I won’t go in on it. NUVB looks like it is trying to break. Got in the dip at MVST. Looking like most of my current ones are a bit longer term. Will check out TPET & SIDU. Check out DXST. :)
Alright so is this Iran bombing gonna mess with NUVB or what..
NUVB drug was preapproved by FDA on Jun 11th. Final approval expected tomorrow. The company was started by Dr. David Wang who sold his last company valued at around 400 mill for 14 billion to Pfizer. 60% institutional ownership. I’m locked in with 1000 shares. Current price: 1.96
Fuck all the haters, bought in NUVB the other week and got chirped. Sold today in the green.... Suck it! Next play is pwdy when it dips back to 0.0012 I think 🤔 I'm 3/3 right now let's see if I can make it 4/4
From what I’ve read the next catalyst event for NUVB would be the phase 1 data from NUV-868, something to do with tumors, or has this already happened as well ? Cause I was waiting for fda approval for another drug Monday and then found out it’s already been approved..
Who here is on the NUVB train? I don't want to say I called it but I called it!
NUVB broke the wall haha! Suck on that shorts!
NUVB is starting to run hahaha, fuck yeah. If it hits 1.98 she gone!!!
NUVB is primed for the MOASS, short shares available are so low since price was at 1.7ish now sitting steady at 1.9. anymore upward price movement could send it. Last reported short interest was 18% safe to say it's higher then that now and positive news with FDA approval already with more upcoming catalysts on the way!
NUVB baby, price seems steady and short shares available since Tuesday have been so low. Makes me think it is going to moon if the price continues to climb much more. MOASS come on baby, Daddy needs some money 🤑🤑💰💰💰
LMAO told you NUVB would bounce back
NUVB starting to move, mentioned that one a few days ago. Still gotta do some DD yourself. Still people here trying to pump NCNA and hcti when they will most likely drop significantly soon. If it's already ran like 300% it's not worth the risk imo, fomo is real here and bag holders complain after making incredibly high risk plays without doing any DD.
Not I, NUVB is hooking me up good today!
When should I buy into NUVB
NUVB with some strong insider purchases https://www.tipranks.com/news/insider-trading/nuvation-bio-executives-make-major-stock-purchases-insider-trading
All you NUVB haters, pay attention these next few days lol. Get in quick if you haven't yet. Another FDA approval coming up, possible commercialization strategy about to be revealed, strong leadership, and high short interest. Congrats to those who bought and held!
The most significant upcoming catalyst for Nuvation Bio (NUVB) is the potential FDA approval of taletrectinib, a novel ROS1 inhibitor for ROS1+ non-small cell lung cancer (NSCLC). This decision is expected on or before June 23, 2025
NUVB recovering ahead of Mondays news
NUVB’s Taletrectinib is already approved fellas and stock tanked ever since. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-taletrectinib-ros1-positive-non-small-cell-lung-cancer?utm_source=chatgpt.com